The Cutaneous Lymphoma Foundation wishes to thank all those who applied. Completed application packages are being reviewed by the Scientific Review Board and recipients will be notified by November 1, 2014.
The applications process for the 2015 CLARIONS begins February 24, 2015.
Questions about the application process should be submitted to Holly Priebe at firstname.lastname@example.org or by calling 248‐644‐9014, extension 6.
The CLF is pleased to announce Leandro Cerchietti, MD, Assistant Professor, Weill Cornell Medical College, and Rachael Clark, MD, PhD, Associate Professor, Brigham and Women's Hospital Department of Dermatology as the recipients of the 2013 CLARIONS Research Award Grant. Dr. Cerchietti’s research focuses on thyroid hormone receptor modulation in CTCL treatment and Dr. Clark’s research centers on low dose external radiation as a cure for skin resident T-cell lymphomas. Read more...
Discovering new avenues for improved therapies and a cure for cutaneous lymphoma
In March 2012, the Cutaneous Lymphoma Foundation’s Board of Directors approved a new Research Awards Program, the first dedicated exclusively to funding cutaneous lymphoma research.
The signature funding initiative of the Research Awards Program (RAP), is the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions. This research grant program supports investigators interested in conducting innovative cutaneous lymphoma research. These grants will help uncover causes and improve the treatment and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key goals of this program.
“As someone who has worked with the Foundation since its inception, it’s especially rewarding to see the launch of the CLARIONS grant program. We’ve been hearing the voices of our patients who have shown tremendous interest in research. We are thrilled to bring this program to the cutaneous lymphoma community,” commented Stuart R. Lessin, M.D., President of the Cutaneous Lymphoma Foundation.
“Research is a vital part of the mission of the Cutaneous Lymphoma Foundation, and we’re committed to funding promising cutaneous lymphoma research. We look forward to working collaboratively with scientists, clinicians, patients, supporters and partners who share in our passion for bringing improved treatments to patients,” expressed Pierluigi Porcu, M.D., the Foundation’s Medical Affairs Research Committee Chair and Associate Professor of Internal Medicine, Division of Hematology, Ohio State University Comprehensive Cancer Center.